Where does Cytori Therapeutics, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Cytori Therapeutics, Inc. ranks #20,982 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Cytori Therapeutics, Inc. hold?

Cytori Therapeutics, Inc. holds 13 US utility patents granted between 2015 and 2018, spanning 7 technology areas.

What is Cytori Therapeutics, Inc.'s Innovation Score?

Cytori Therapeutics, Inc. has an Innovation Score of 31.9 out of 100 (39th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Cytori Therapeutics, Inc.'s patent grant rate increasing or decreasing?

Cytori Therapeutics, Inc.'s recent grant velocity is -100% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Cytori Therapeutics, Inc.'s patents?

Cytori Therapeutics, Inc.'s patents average 22.5 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Cytori Therapeutics, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Cytori Therapeutics, Inc.

Q: What technology areas does Cytori Therapeutics, Inc. focus on?

Cytori Therapeutics, Inc.'s top technology area is C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media) with 13 patents, ranking #809 of 4,144 assignees active in that subclass. Grants appear in 7 CPC subclasses total.

USPTO PatentsView assignee record - 13 granted patents across 7 technology areas, recorded in grant years 2015–2018. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Cytori ranks #20,982 of 49,997 tracked US assignees by granted-patent volume, with 13 patents across 7 technology areas.

#20,982
of 49,997 US assignees by volume: 39th percentile
by Innovation Score (31.9/100): 22.5
avg claims per patent: -100%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R20982 · US Corporation #20,982 · 13 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-DENSE · TYPE-USCORP · VEL-DROP · BOOK-FULL

GRANTS-MICRO 13 grants
MID-PACK #20,982/49,997
PHOTO-FINISH California Eastern…
CPC-NARROW C12N · 7 areas
INNOV-THIN 31.9/100
CLAIMS-DENSE 22.5 claims/avg
TYPE-USCORP US Corporation
VEL-DROP -100% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: California Eastern Laboratories, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Cytori’s 31.9 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 9.1 pts (28%) Velocity 0.0 pts (0%) Breadth 9.4 pts (29%) Claim depth 13.5 pts (42%)

Qualcomm Incorporated · highest

85
Amphenol-tuchel · near

32
Cytori Therapeutics · this assignee

32
Husky · near

32
Miro · near

32
Thermo Fisher… · near

32
3D Lighting… · lowest

7

What this shows Cytori's Innovation Score is 31.9/100 (39th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Cytori?

Each dot is one of Cytori’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Cytori’s own 22.5 claims/patent is ABOVE the 20.1 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Cytori vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Cytori's grants concentrate

Cytori Therapeutics, Inc. is a focused PatentsView assignee: 7 CPC subclasses with 100% of grants classified under C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media). Peak complete grant year is 2016 (8 grants) versus a trough of 1 in 2015. By volume, Cytori sits between Crystal Lagoons (CURACAO) B.V. and CareBand, Inc..

Crystal Lagoons (…

13
CS Disco

13
CSL Behring Lengn…

13
CW Holdings

13
California Easter…

13
Canburg

13
Carbon Engineering

13
Careband

13
Cytori Therapeuti… ◀

13

What this shows Cytori holds 13 patents at rank #20,928, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Cytori

By rank, the assignees closest to #20,928 in granted patent volume.

Leaders in C12N (Microorganisms OR Enzymes)

Other assignees with the most granted patents in Cytori's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Cytori, neither rank-band nor same-CPC leaders (those blocks stay above). In C12N (Microorganisms OR Enzymes), Cytori ranks #809 of 4,144 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (32 here).

Thermo Fisher Scientific (Asheville) LLC 32 Husky Corporation 32 Amphenol-tuchel Electronics GMBH 32 Miro Co., Ltd. 32

Cytori's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

32 39th percentile higher than 39% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2018

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Cytori Therapeutics, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	1	7.7%
2016	8	61.5%
2017	2	15.4%
2018	2	15.4%

Which technologies does Cytori Therapeutics, Inc. patent most?

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 13

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 13

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 10

A61L - Methods OR Apparatus FOR Sterilising Materials OR Objects IN GENERAL; Disinfection, Sterilisation OR Deodorisation OF AIR; Chemical Aspects OF Bandages, Dressings, Absorbent Pads OR Surgical ARTICLES; Materials FOR Bandages, Dressings, Absorbent Pads OR Surgical Articles 9

A61B - DIAGNOSIS; SURGERY; Identification 2

C12M - Apparatus FOR Enzymology OR MICROBIOLOGY; Apparatus FOR Culturing Microorganisms FOR Producing Biomass, FOR Growing Cells OR FOR Obtaining Fermentation OR Metabolic Products, i.e. Bioreactors OR Fermenters 2

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 2

Top 7 of 7 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Cytori Therapeutics, Inc.'s patent record in context - here's where to go next.

Cytori Therapeutics, Inc.'s lead technology class is C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media), 100% of its portfolio - see every assignee active in that class. Explore C12N
Ranked #20,982 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Cytori Therapeutics, Inc. against Crystal Lagoons (CURACAO) B.V., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 31.9/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.